240 related articles for article (PubMed ID: 8382119)
1. Assessment of endocrine function after transsphenoidal surgery for Cushing's disease.
McCance DR; Gordon DS; Fannin TF; Hadden DR; Kennedy L; Sheridan B; Atkinson AB
Clin Endocrinol (Oxf); 1993 Jan; 38(1):79-86. PubMed ID: 8382119
[TBL] [Abstract][Full Text] [Related]
2. Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment.
Trainer PJ; Lawrie HS; Verhelst J; Howlett TA; Lowe DG; Grossman AB; Savage MO; Afshar F; Besser GM
Clin Endocrinol (Oxf); 1993 Jan; 38(1):73-8. PubMed ID: 8435888
[TBL] [Abstract][Full Text] [Related]
3. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
[TBL] [Abstract][Full Text] [Related]
4. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit.
Yap LB; Turner HE; Adams CB; Wass JA
Clin Endocrinol (Oxf); 2002 Jan; 56(1):25-31. PubMed ID: 11849243
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Cushing's disease by transsphenoidal, pituitary microsurgery: prognosis factors and long-term follow-up.
Bakiri F; Tatai S; Aouali R; Semrouni M; Derome P; Chitour F; Benmiloud M
J Endocrinol Invest; 1996 Oct; 19(9):572-80. PubMed ID: 8957739
[TBL] [Abstract][Full Text] [Related]
6. Endocrine function in patients with Cushing's disease before and after treatment.
Lindholm J
Clin Endocrinol (Oxf); 1992 Feb; 36(2):151-9. PubMed ID: 1314723
[TBL] [Abstract][Full Text] [Related]
7. Postoperative plasma cortisol levels predict long-term outcome in patients with Cushing's disease and determine which patients should be treated with pituitary irradiation after surgery.
Imaki T; Tsushima T; Hizuka N; Odagiri E; Murata Y; Suda T; Takano K
Endocr J; 2001 Feb; 48(1):53-62. PubMed ID: 11403103
[TBL] [Abstract][Full Text] [Related]
8. A critical evaluation of transsphenoidal pituitary surgery in the treatment of Cushing's disease: prediction of outcome.
Arnott RD; Pestell RG; McKelvie PA; Henderson JK; McNeill PM; Alford FP
Acta Endocrinol (Copenh); 1990 Oct; 123(4):423-30. PubMed ID: 2173325
[TBL] [Abstract][Full Text] [Related]
9. High prolactin levels in patients with Cushing's disease without pathological evidence of pituitary adenoma.
Comtois R; Beauregard H; Hardy J; Robert F; Somma M
Clin Endocrinol (Oxf); 1993 Jun; 38(6):601-7. PubMed ID: 8392915
[TBL] [Abstract][Full Text] [Related]
10. Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome?
Chee GH; Mathias DB; James RA; Kendall-Taylor P
Clin Endocrinol (Oxf); 2001 May; 54(5):617-26. PubMed ID: 11380492
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission.
Rees DA; Hanna FW; Davies JS; Mills RG; Vafidis J; Scanlon MF
Clin Endocrinol (Oxf); 2002 Apr; 56(4):541-51. PubMed ID: 11966748
[TBL] [Abstract][Full Text] [Related]
12. Transsphenoidal surgery for Cushing's disease: endocrinological follow-up monitoring of 82 patients.
Shimon I; Ram Z; Cohen ZR; Hadani M
Neurosurgery; 2002 Jul; 51(1):57-61; discussion 61-2. PubMed ID: 12182435
[TBL] [Abstract][Full Text] [Related]
13. Investigation, management and therapeutic outcome in 12 cases of childhood and adolescent Cushing's syndrome.
Weber A; Trainer PJ; Grossman AB; Afshar F; Medbak S; Perry LA; Plowman PN; Rees LH; Besser GM; Savage MO
Clin Endocrinol (Oxf); 1995 Jul; 43(1):19-28. PubMed ID: 7641408
[TBL] [Abstract][Full Text] [Related]
14. Predicting relapse after transsphenoidal surgery for Cushing's disease.
Toms GC; McCarthy MI; Niven MJ; Orteu CH; King TT; Monson JP
J Clin Endocrinol Metab; 1993 Feb; 76(2):291-4. PubMed ID: 8432771
[TBL] [Abstract][Full Text] [Related]
15. [Transsphenoidal hypophysectomy of a patient with an ACTH-producing pituitary adenoma and an "empty sella" after pretreatment with etomidate].
Herrmann BL; Mitchell A; Saller B; Stolke D; Forsting M; Frilling A; Mann K
Dtsch Med Wochenschr; 2001 Mar; 126(9):232-4. PubMed ID: 11256037
[TBL] [Abstract][Full Text] [Related]
16. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430
[TBL] [Abstract][Full Text] [Related]
17. Postoperative metyrapone test in the early assessment of outcome of pituitary surgery for Cushing's disease.
van Aken MO; de Herder WW; van der Lely AJ; de Jong FH; Lamberts SW
Clin Endocrinol (Oxf); 1997 Aug; 47(2):145-9. PubMed ID: 9302385
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and long-term outcome in pituitary-dependent Cushing's disease.
Sonino N; Zielezny M; Fava GA; Fallo F; Boscaro M
J Clin Endocrinol Metab; 1996 Jul; 81(7):2647-52. PubMed ID: 8675592
[TBL] [Abstract][Full Text] [Related]
19. Assessment of cure after transsphenoidal surgery for Cushing's disease.
McCance DR; Besser M; Atkinson AB
Clin Endocrinol (Oxf); 1996 Jan; 44(1):1-6. PubMed ID: 8706280
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease.
Storr HL; Afshar F; Matson M; Sabin I; Davies KM; Evanson J; Plowman PN; Besser GM; Monson JP; Grossman AB; Savage MO
Eur J Endocrinol; 2005 Jun; 152(6):825-33. PubMed ID: 15941921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]